about
SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurityDiastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels.Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations.The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction.Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney diseaseImpact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery diseaseContribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxinsVasoactive renal factors and the progression of diabetic nephropathy.Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditionsThioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway.BK virus RNA can be detected in archival renal transplant biopsies using the reverse trancription polymerase chain reaction.Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions.Cannabinoid receptor 2 expression in human proximal tubule cells is regulated by albumin independent of ERK1/2 signaling.Cardiac fibrosis in the ageing heart: contributors and mechanisms.Protein kinase C β inhibition ameliorates experimental mesangial proliferative glomerulonephritis.PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.Early and delayed tranilast treatment reduces pathological fibrosis following myocardial infarction.COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity.Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy.Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo.Effect of atorvastatin on cardiac remodelling and mortality in rats following hyperglycemia and myocardial infarction.Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 rats.High glucose induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.Vitamin D(2) supplementation induces the development of aortic stenosis in rabbits: interactions with endothelial function and thioredoxin-interacting protein.Renin inhibition: new potential for an old therapeutic target.Chronic intermittent hypoxia accelerates coronary microcirculatory dysfunction in insulin-resistant Goto-Kakizaki rats.FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?Neonatal calyceal dilation and renal fibrosis resulting from loss of Adamts-1 in mouse kidney is due to a developmental dysgenesis.Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetesEffects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 ratRenal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats11See Editorial by Border and Noble, p. 1390Adrenaline cells of the rat adrenal cortex and medulla contain renin and proreninAngiotensin II-induced proteinuria and expression of the podocyte slit pore membrane protein, nephrinFunctional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 ratIncreased expression of urotensin II and urotensin II receptor in human diabetic nephropathyClinically relevant models of diabetic cardiac complicationsDynamic synchrotron imaging of diabetic rat coronary microcirculation in vivoDifferences in myocardial structure and coronary microvasculature between men and women with coronary artery diseaseAtrial protective effects of n-3 polyunsaturated fatty acids: a long-term study in ovine chronic heart failure
P50
Q28571768-74A7A0C3-5CD5-4559-85FD-13945A14192BQ34493878-E3A83490-7285-424F-AE53-2D63B208C125Q34583579-3D1C8847-311E-4A24-A3E5-658B17532796Q35071066-4A7A7301-64DF-4D21-82EA-8DA61A382767Q35217148-1404DA76-8DB3-4280-AB93-DC7171CE0BEBQ35240672-DAED9C1D-D47F-46B3-B84D-D3F9A42CEA8DQ35588665-488CCF65-4B19-4173-A1C4-4D9692EBB91BQ35950295-DF0145BE-C758-4AA4-B642-87030C17C7D4Q35971694-B460A9D0-DDC4-4C14-8829-DC8673DFF0FEQ37067721-E8C3E63E-986A-4B02-B9C8-B1F907209B2DQ38423795-220E1BE8-D9BB-476E-A8C0-F6AD6098BBEDQ38924783-8A1D0E2E-9E84-410A-9A9B-45B33DBB5EF9Q39053950-6D3FC44A-B6A1-47A4-A0B4-002E18D62B54Q39186232-826DCD1C-A0B5-4422-A550-32E22A0CA06EQ39541841-24B6F06C-1115-4583-90E2-4CB5F5A0B29FQ40819492-4F4C5C49-E969-446E-9FF1-9E9B8735032BQ43599637-7D0ACBD8-D986-4E4A-A48C-268E32CD8DDDQ44324713-73161808-49D2-4119-BA3C-49E3F1A8A123Q44512781-D3A12B03-A42A-48B0-9E91-19C424BFA208Q44936586-28474B2B-836E-44A5-B99E-09502FE2660EQ46036398-E2F762F5-E8CD-4B14-8193-7D0C6EB3BF43Q46338965-E58F4519-D23B-43AD-B7A7-638E7F5EDAC3Q46436440-CF9C6A34-3FE5-4B41-B743-8E1F3F8711CCQ46514461-7948338F-8C28-4AA3-A654-EDF330CE9CD3Q46652751-50F452CD-10A9-4D14-A9A0-FC3F30443A09Q48215443-C8C2E366-51D2-40FE-8421-58234E6ACFACQ50515046-48071C1D-1C7F-4FAB-AE51-E0C98017CE8DQ50985567-FD7ADA23-F46E-4F21-8BC8-19BA9188EE2BQ52061819-0213FD71-AF85-4B82-BA80-C4BCCA362131Q60169563-7D7DE723-4D95-4786-96DC-EC95CA9219BEQ60169570-00776880-C4A9-4CC3-AF2B-F757A6594FA3Q60169574-4989A94D-2D30-4057-AAAD-6E43C17B9EB0Q60169584-5C8C897E-D1C0-4E14-AF62-8D1405C902C5Q79362173-10A5F57D-5448-40F8-AD73-6054111838BEQ80837269-4902C7EB-98B0-425A-8F18-53D1F91A884AQ80880875-F2C2B5D4-29FE-4B3A-9A2D-9DDC7FBE8BA9Q81301708-39819C13-02B6-434B-9D24-E2C1F3F3B5B9Q82462283-2FDB9B1D-7F57-4550-BD46-53A4816B255FQ82767312-F9788A63-1C13-4025-B9CA-7C321CCBF15FQ82822348-096D3F41-58D1-4EB8-A3C5-A96061007ACB
P50
description
researcher ORCID ID = 0000-0003-4850-3929
@en
name
Darren J Kelly
@ast
Darren J Kelly
@en
Darren J Kelly
@es
Darren J Kelly
@nl
type
label
Darren J Kelly
@ast
Darren J Kelly
@en
Darren J Kelly
@es
Darren J Kelly
@nl
prefLabel
Darren J Kelly
@ast
Darren J Kelly
@en
Darren J Kelly
@es
Darren J Kelly
@nl
P1153
7403137489
P31
P496
0000-0003-4850-3929